Prevention and treatment of acute graft-versus-host disease.
D000208:Acute Disease; D000818:Animals; D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D003524:Cyclosporins / Q000627:therapeutic use; D006082:Graft Enhancement, Immunologic; D006086:Graft vs Host Disease / Q000188:drug therapy / Q000517:prevention & control*; D006648:Histocompatibility; D006801:Humans; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D037102:Lectins / Q000494:pharmacology; D008212:Lymphocyte Depletion; D008727:Methotrexate / Q000627:therapeutic use; D008775:Methylprednisolone / Q000627:therapeutic use; D037121:Plant Lectins; D012276:Ricin / Q000494:pharmacology; D030262:Soybean Proteins; D013025:Glycine max; D013601:T-Lymphocytes / Q000276:immunology; D010835:Phytohemagglutinins
D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D003524:Cyclosporins; D007166:Immunosuppressive Agents; D037102:Lectins; D008727:Methotrexate; D008775:Methylprednisolone; D037121:Plant Lectins; D012276:Ricin; D030262:Soybean Proteins; C028824:soybean lectin; D010835:Phytohemagglutinins